Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-20-122483
Filing Date
2020-11-06
Accepted
2020-11-06 16:02:09
Documents
5
Effectiveness Date
2020-11-06

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm2034702-1_s3asr.htm S-3ASR 461328
2 EX-5.1 tm2034702-exh5_1.htm EX-5.1 29255
3 EX-23.1 tm2034702-exh23_1.htm EX-23.1 3137
4 GRAPHIC lg_cantor-4c.jpg GRAPHIC 9453
5 GRAPHIC lg_celldextherapeutics-4c.jpg GRAPHIC 204822
  Complete submission text file 0001104659-20-122483.txt   790358
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

EIN.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-249917 | Film No.: 201294350
SIC: 2835 In Vitro & In Vivo Diagnostic Substances